164 related articles for article (PubMed ID: 36245263)
1. Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers.
McKenna DB; Sanchez P; Powers J; Brower J; Wang L; Mueller R; Symecko H; Hamilton JG; Wildman T; Domchek SM; Couch FJ; Garber JE; Offit K; Robson ME; Katona BW
J Genet Couns; 2023 Apr; 32(2):342-350. PubMed ID: 36245263
[TBL] [Abstract][Full Text] [Related]
2. Risk of colorectal adenomas and cancer in monoallelic carriers of MUTYH pathogenic variants: a single-centre experience.
Patel R; McGinty P; Cuthill V; Hawkins M; Clark SK; Latchford A
Int J Colorectal Dis; 2021 Oct; 36(10):2199-2204. PubMed ID: 34244858
[TBL] [Abstract][Full Text] [Related]
3. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer.
Win AK; Dowty JG; Cleary SP; Kim H; Buchanan DD; Young JP; Clendenning M; Rosty C; MacInnis RJ; Giles GG; Boussioutas A; Macrae FA; Parry S; Goldblatt J; Baron JA; Burnett T; Le Marchand L; Newcomb PA; Haile RW; Hopper JL; Cotterchio M; Gallinger S; Lindor NM; Tucker KM; Winship IM; Jenkins MA
Gastroenterology; 2014 May; 146(5):1208-11.e1-5. PubMed ID: 24444654
[TBL] [Abstract][Full Text] [Related]
4. Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.
Ukaegbu C; Levi Z; Fehlmann TD; Uno H; Chittenden A; Inra JA; Grover S; Kastrinos F; Syngal S; Yurgelun MB
Fam Cancer; 2021 Apr; 20(2):111-116. PubMed ID: 32743790
[TBL] [Abstract][Full Text] [Related]
5. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH.
Jones N; Vogt S; Nielsen M; Christian D; Wark PA; Eccles D; Edwards E; Evans DG; Maher ER; Vasen HF; Hes FJ; Aretz S; Sampson JR
Gastroenterology; 2009 Aug; 137(2):489-94, 494.e1; quiz 725-6. PubMed ID: 19394335
[TBL] [Abstract][Full Text] [Related]
6. MUTYH hotspot mutations in unselected colonoscopy patients.
Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
[TBL] [Abstract][Full Text] [Related]
7. Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort.
Fulk K; LaDuca H; Black MH; Qian D; Tian Y; Yussuf A; Espenschied C; Jasperson K
Fam Cancer; 2019 Apr; 18(2):197-201. PubMed ID: 30582135
[TBL] [Abstract][Full Text] [Related]
8. Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures.
Georgeson P; Harrison TA; Pope BJ; Zaidi SH; Qu C; Steinfelder RS; Lin Y; Joo JE; Mahmood K; Clendenning M; Walker R; Amitay EL; Berndt SI; Brenner H; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Doheny KF; Drew DA; Figueiredo JC; French AJ; Gallinger S; Giannakis M; Giles GG; Gsur A; Gunter MJ; Hoffmeister M; Hsu L; Huang WY; Limburg P; Manson JE; Moreno V; Nassir R; Nowak JA; Obón-Santacana M; Ogino S; Phipps AI; Potter JD; Schoen RE; Sun W; Toland AE; Trinh QM; Ugai T; Macrae FA; Rosty C; Hudson TJ; Jenkins MA; Thibodeau SN; Winship IM; Peters U; Buchanan DD
Nat Commun; 2022 Jun; 13(1):3254. PubMed ID: 35668106
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study.
El Hachem N; Abadie C; Longy M; Colas C; Fert-Ferrer S; Leroux D; Grandval P; Prieur F; Collonge-Rame M; Faivre L; Fricker JP; Zerbib F; Coupier I; Cauchin E; Pinson S; Saurin JC
Dis Colon Rectum; 2019 Apr; 62(4):470-475. PubMed ID: 30640315
[TBL] [Abstract][Full Text] [Related]
10. Breast cancers in monoallelic MUTYH germline mutation carriers have clinicopathological features overlapping with those in BRCA1 germline mutation carriers.
Keske A; Weisman P; Ospina-Romero M; Raut P; Smith-Simmer K; Zakas AL; Flynn C; Xu J
Breast Cancer Res Treat; 2024 Feb; 204(1):151-158. PubMed ID: 38062336
[TBL] [Abstract][Full Text] [Related]
11. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.
Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870
[TBL] [Abstract][Full Text] [Related]
12. Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer.
Thompson AB; Sutcliffe EG; Arvai K; Roberts ME; Susswein LR; Marshall ML; Torene R; Postula KJV; Hruska KS; Bai S
Fam Cancer; 2022 Oct; 21(4):415-422. PubMed ID: 34981295
[TBL] [Abstract][Full Text] [Related]
13. Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis.
Barreiro RAS; Sabbaga J; Rossi BM; Achatz MIW; Bettoni F; Camargo AA; Asprino PF; A F Galante P
J Pathol; 2022 Feb; 256(2):214-222. PubMed ID: 34816434
[TBL] [Abstract][Full Text] [Related]
14. MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
Morak M; Laner A; Bacher U; Keiling C; Holinski-Feder E
Clin Genet; 2010 Oct; 78(4):353-63. PubMed ID: 20618354
[TBL] [Abstract][Full Text] [Related]
15. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
Rosner G; Bercovich D; Daniel YE; Strul H; Fliss-Isakov N; Ben-Yehoiada M; Santo E; Halpern Z; Kariv R
Fam Cancer; 2015 Sep; 14(3):427-36. PubMed ID: 25822476
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America.
Esperon P; Neffa F; Pavicic W; Spirandelli F; Alvarez K; Mullins MJ; Rossi BM; Góngora E Silva RF; Vaccaro C; Lopéz-Köstner F; Rugeles J; Valle AD; Dominguez-Valentin M
Fam Cancer; 2024 Apr; ():. PubMed ID: 38687439
[TBL] [Abstract][Full Text] [Related]
17. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing.
Riegert-Johnson DL; Johnson RA; Rabe KG; Wang L; Thomas B; Baudhuin LM; Thibodeau SN; Boardman LA
Genet Test; 2007; 11(4):361-5. PubMed ID: 18294051
[TBL] [Abstract][Full Text] [Related]
18. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.
Win AK; Cleary SP; Dowty JG; Baron JA; Young JP; Buchanan DD; Southey MC; Burnett T; Parfrey PS; Green RC; Le Marchand L; Newcomb PA; Haile RW; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
Int J Cancer; 2011 Nov; 129(9):2256-62. PubMed ID: 21171015
[TBL] [Abstract][Full Text] [Related]
19. MUTYH-associated tumor syndrome: The other face of MAP.
Magrin L; Fanale D; Brando C; Corsini LR; Randazzo U; Di Piazza M; Gurrera V; Pedone E; Bazan Russo TD; Vieni S; Pantuso G; Russo A; Bazan V
Oncogene; 2022 Apr; 41(18):2531-2539. PubMed ID: 35422474
[TBL] [Abstract][Full Text] [Related]
20. Simplifying the detection of MUTYH mutations by high resolution melting analysis.
López-Villar I; Ayala R; Wesselink J; Morillas JD; López E; Marín JC; Díaz-Tasende J; González S; Robles L; Martínez-López J
BMC Cancer; 2010 Aug; 10():408. PubMed ID: 20687945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
